Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Pasithea Therapeutics Corp. KTTAW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — KTTAW

No analyst consensus data available for KTTAW.

People Also View

KTTA
KTTA
Pasithea Therapeutics Corp.
$0.72
-8.61%
 BFRIW
BFRIW
Biofrontera Inc.
$0.03
-14.53%
 JSPRW
JSPRW
Jasper Therapeutics, Inc.
$0.02
+0.48%
 LIXTW
LIXTW
Lixte Biotechnology Holdings, Inc.
$0.02
+100.00%
 DRMAW
DRMAW
Dermata Therapeutics, Inc.
$0.01
-22.91%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message